1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Matrix-assisted laser desorption ionization - mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non-small-cell lung cancer mouse xenograft model
(
- Contribution to journal › Letter
- 2020
-
Mark
Dna polymerase alpha subunit b is a binding protein for erlotinib resistance in non-small cell lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
(
- Contribution to journal › Article
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
(
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
(
- Contribution to journal › Article
-
Mark
The hidden story of heterogeneous B-raf V600E mutation quantitative protein expression in metastatic melanoma—association with clinical outcome and tumor phenotypes
(
- Contribution to journal › Article
- 2018
-
Mark
Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
(
- Contribution to journal › Article
-
Mark
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
(
- Contribution to journal › Article
- 2017
-
Mark
Cancer heterogeneity determined by functional proteomics
(
- Contribution to journal › Article
-
Mark
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
(
- Contribution to journal › Article